Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.79 Analyst target: $9.62 Upside: 437.43%
Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.